James C.  Lim net worth and biography

James Lim Biography and Net Worth

James Lim serves as executive vice president and president of Greater Asia for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. He is also a member of the BD Executive Leadership Team. Based in Singapore, where BD’s Greater Asia regional headquarters is located, Lim leads the company’s business operations in China, Japan, Taiwan, Hong Kong, Australia, New Zealand, Korea, Southeast Asia, India and Pakistan.

Lim joined BD in 1994 from Seagate International, serving initially as an engineering and facility manager for BD Medical, then working in research and development, and eventually serving as a plant manager. He was then promoted to director of operations for the Asia Pacific region and was responsible for regional Manufacturing and Supply Chain functions, overseeing plant operations in Singapore, Bawal, India and Suzhou, China. He was then named vice president for both the Central and Asia Pacific regions, responsible for business management and support functions for the entire Asia Pacific region.

Lim earned a degree in mechanical engineering from the National University of Singapore.

What is James C. Lim's net worth?

The estimated net worth of James C. Lim is at least $8.18 million as of September 6th, 2019. Mr. Lim owns 33,041 shares of Becton, Dickinson and Company stock worth more than $8,175,995 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Lim may own. Learn More about James C. Lim's net worth.

How do I contact James C. Lim?

The corporate mailing address for Mr. Lim and other Becton, Dickinson and Company executives is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. Becton, Dickinson and Company can also be reached via phone at (201) 847-6800 and via email at [email protected]. Learn More on James C. Lim's contact information.

Has James C. Lim been buying or selling shares of Becton, Dickinson and Company?

James C. Lim has not been actively trading shares of Becton, Dickinson and Company during the last ninety days. Most recently, James C. Lim sold 6,956 shares of the business's stock in a transaction on Friday, September 3rd. The shares were sold at an average price of $257.44, for a transaction totalling $1,790,752.64. Learn More on James C. Lim's trading history.

Who are Becton, Dickinson and Company's active insiders?

Becton, Dickinson and Company's insider roster includes Simon Campion (EVP), Alexandre Conroy (EVP), Christopher DelOrefice (Exec. VP & CFO ), Claire Fraser (Director), John Gallagher (VP), Michael Garrison (EVP), Roland Goette (EVP), David Hickey (EVP), Patrick Kaltenbach (EVP), Samrat Khichi (EVP), Betty Larson (EVP), James Lim (EVP), Thomas Polen, Jr. (Insider), Rebecca Rimel (Director), and Thomas Spoerel (VP). Learn More on Becton, Dickinson and Company's active insiders.

Are insiders buying or selling shares of Becton, Dickinson and Company?

During the last year, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 8,019 shares worth more than $2,132,768.00. The most recent insider tranaction occured on March, 14th when SVP Thomas J Spoerel sold 282 shares worth more than $67,197.78. Insiders at Becton, Dickinson and Company own 0.3% of the company. Learn More about insider trades at Becton, Dickinson and Company.

Information on this page was last updated on 3/14/2024.

James C. Lim Insider Trading History at Becton, Dickinson and Company

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/3/2021Sell6,956$257.44$1,790,752.64View SEC Filing Icon  
9/6/2019Sell9,299$263.53$2,450,565.4733,041View SEC Filing Icon  
8/8/2019Sell1,929$252.01$486,127.29View SEC Filing Icon  
11/8/2018Sell5,189$242.36$1,257,606.0413,318View SEC Filing Icon  
5/9/2016Sell5,257$165.60$870,559.2012,556View SEC Filing Icon  
5/18/2015Sell3,604$141.80$511,047.20View SEC Filing Icon  
See Full Table

James C. Lim Buying and Selling Activity at Becton, Dickinson and Company

This chart shows James C Lim's buying and selling at Becton, Dickinson and Company by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Becton, Dickinson and Company Company Overview

Becton, Dickinson and Company logo
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Read More

Today's Range

Now: $247.45
Low: $245.33
High: $248.42

50 Day Range

MA: $239.20
Low: $233.57
High: $246.53

2 Week Range

Now: $247.45
Low: $229.85
High: $287.32

Volume

1,093,920 shs

Average Volume

1,475,061 shs

Market Capitalization

$71.49 billion

P/E Ratio

58.64

Dividend Yield

1.57%

Beta

0.42